# Ibrance

NDC: 0069-0189
Generic name: palbociclib
Labeler / Manufacturer: Pfizer Laboratories Div Pfizer Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20150203

FDA application: NDA207103

## Active ingredients

- PALBOCICLIB: 125 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0069-0189"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0069-0189
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e0e6412f-50b4-4fd4-9364-62818d121a07